Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R.
Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850.
The Neurofibromatoses.
Farschtschi S, Mautner VF, McLean ACL, Schulz A, Friedrich RE, Rosahl SK.
Dtsch Arztebl Int. 2020 May 15;117(20):354-360. doi: 10.3238/arztebl.2020.0354.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Neurofibromatosis.
Korf BR.
Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7.
Living with neurofibromatosis.
Murphy L, Andrawis M, Beatty P, Costa Blasco M, Doyle C, McFeely O, O'Mahony S, Wolinska A, Connolly M.
Clin Exp Dermatol. 2023 Sep 19;48(10):1192-1193. doi: 10.1093/ced/llad228.
[Segmental neurofibromatosis].
Wagner G, Meyer V, Sachse MM.
Hautarzt. 2018 Jun;69(6):487-490. doi: 10.1007/s00105-017-4078-1.
Neurofibromatosis update.
Crawford AH, Schorry EK.
J Pediatr Orthop. 2006 May-Jun;26(3):413-23. doi: 10.1097/01.bpo.0000217719.10728.39.
Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.
Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A.
Am J Med Genet A. 2023 Oct;191(10):2467-2481. doi: 10.1002/ajmg.a.63346. Epub 2023 Jul 24.
[Eye involvement in neurofibromatosis].
Baier M, Pitz S.
Ophthalmologe. 2016 May;113(5):443-52. doi: 10.1007/s00347-016-0237-5.
Segmental neurofibromatosis.
Toy B.
Dermatol Online J. 2003 Oct;9(4):26.
